Sio Partners Targets Cancer Treatments and SPACs for Growth

Sio Partners, the specialist healthcare hedge fund, returned 0.9% net of fees and expenses in January, compared to a loss of -1% for the S&P 500 and a gain of 1% for the MSCI World Healthcare Index. Long investments contributed 12.6%, according to a copy of the firm’s letter, which ValueWalk has been able to review, while short positions detracted -10.7% from the performance. Q4 2020 hedge fund letters, conferences and more Since its inception in June 2006, Sio has returned 10.6% per annum, compared to 13.3% for the MSCI World Healthcare benchmark. In 2020, Sio added 11.3% net of…